| Raliat Biola Abdulai, | |
|
1100 New Jersey Ave Se Ste 845, Washington, DC 20003-3338 | |
| (202) 545-6980 | |
| Not Available |
| Full Name | Raliat Biola Abdulai |
|---|---|
| Gender | Female |
| Speciality | Licensed Practical Nurse |
| Location | 1100 New Jersey Ave Se Ste 845, Washington, District Of Columbia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174139901 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164W00000X | Licensed Practical Nurse | LPN1005523 (District Of Columbia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Raliat Biola Abdulai, 3207 Riva Ridge Ct, Bowie, MD 20721-1282 Ph: () - | Raliat Biola Abdulai, 1100 New Jersey Ave Se Ste 845, Washington, DC 20003-3338 Ph: (202) 545-6980 |
News Archive
Researchers at Baylor College of Medicine have identified a group of potential substitutes for bisphenol A (BPA) that lack the adverse effects typically associated with BPA.
New research by the Gladstone Institutes of Cardiovascular Disease (GICD) and the University of California, San Francisco (UCSF), has revealed the genetic determinants of fat storage in cells, which may lead to a new understanding of and potential treatments for obesity, diabetes, and heart disease. While scientists have long understood that lipid droplets contribute to fat build up in cells, the genes involved in droplet biology have been a focus of extensive research.
A review aims to evaluate the effectiveness of physical activity in people with type 2 diabetes and COVID-19.
U.S. Department of Health and Human Services (HHS) Secretary Kathleen Sebelius sent a letter to Chairman George Miller and the Committee on Education and Labor regarding the Government Accountability Office (GAO) investigation into improper practices by Head Start grantees. The investigation is the subject of the Committee's upcoming hearing. Secretary Sebelius' letter outlines HHS's plans and steadfast commitment to upholding the integrity of this critical program.
NanoString Technologies, Inc., a privately held provider of life science tools for translational research and developer of molecular diagnostics, today announced that it is initiating the first in a series of studies to evaluate the clinical utility of the NanoString Breast Cancer Intrinsic Subtyping Assay.
› Verified 4 days ago
Emmanuel Mbu, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 2811 Pennsylvania Ave Se, Washington, DC 20020 Phone: 301-379-8449 | |
Stella Segun, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 6856 Eastern Ave Nw, Suite 220, Washington, DC 20012 Phone: 202-545-6980 | |
Yolanda Blagrove, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 801 Pennsylvania Ave Se, Washington, DC 20003 Phone: 202-796-0605 | |
Nwaneka Onuaku, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 6856 Eastern Ave Nw Ste 320a, Washington, DC 20012 Phone: 202-541-9844 | |
Priscillia N Moghalu, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 6856 Eastern Ave Nw, Washington, DC 20012 Phone: 202-541-9844 | |
Jasmine Rhodes, HHA, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 505 Madison St Nw, Washington, DC 20011 Phone: 202-600-6972 | |
Rochelle Fadare, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 7600 Georgia Ave Nw Ste 323, Washington, DC 20012 Phone: 202-723-3060 Fax: 202-723-3065 |